Candace M. Howard

2.2k total citations
66 papers, 1.7k citations indexed

About

Candace M. Howard is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Candace M. Howard has authored 66 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 17 papers in Genetics and 13 papers in Molecular Biology. Recurrent topics in Candace M. Howard's work include Virus-based gene therapy research (16 papers), Cancer-related Molecular Pathways (11 papers) and Cancer Cells and Metastasis (8 papers). Candace M. Howard is often cited by papers focused on Virus-based gene therapy research (16 papers), Cancer-related Molecular Pathways (11 papers) and Cancer Cells and Metastasis (8 papers). Candace M. Howard collaborates with scholars based in United States, Italy and Spain. Candace M. Howard's co-authors include Pier Paolo Claudio, Antonio Giordano, Alfonso Baldi, Antonio De Luca, M Caputi, Giovan Giacomo Giordano, Feliciano Baldi, Yan Fu, Corrado Minimo and Gianluigi Condorelli and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Candace M. Howard

62 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Candace M. Howard United States 22 963 719 294 227 193 66 1.7k
Caterina Catricalà Italy 29 1.6k 1.6× 639 0.9× 234 0.8× 89 0.4× 221 1.1× 74 2.7k
Ken Berean Canada 23 490 0.5× 708 1.0× 120 0.4× 275 1.2× 183 0.9× 32 2.2k
Nanette J. Liégeois United States 22 1.7k 1.7× 1.8k 2.5× 366 1.2× 189 0.8× 343 1.8× 33 3.1k
Claire Lugassy France 25 778 0.8× 667 0.9× 57 0.2× 197 0.9× 250 1.3× 58 1.9k
Alistair Robson United Kingdom 25 1.4k 1.4× 748 1.0× 149 0.5× 189 0.8× 252 1.3× 101 3.3k
W Domagała Poland 28 912 0.9× 726 1.0× 289 1.0× 290 1.3× 461 2.4× 111 2.0k
Natalia Aptsiauri Spain 31 1.6k 1.7× 726 1.0× 157 0.5× 200 0.9× 175 0.9× 55 2.9k
Keichiro Mihara Japan 21 1.2k 1.2× 914 1.3× 340 1.2× 80 0.4× 252 1.3× 70 2.4k
Tai‐Gyu Kim South Korea 27 639 0.7× 617 0.9× 282 1.0× 91 0.4× 81 0.4× 170 2.3k
Anna Maria Cesinaro Italy 30 1.7k 1.8× 415 0.6× 142 0.5× 295 1.3× 150 0.8× 98 2.8k

Countries citing papers authored by Candace M. Howard

Since Specialization
Citations

This map shows the geographic impact of Candace M. Howard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Candace M. Howard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Candace M. Howard more than expected).

Fields of papers citing papers by Candace M. Howard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Candace M. Howard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Candace M. Howard. The network helps show where Candace M. Howard may publish in the future.

Co-authorship network of co-authors of Candace M. Howard

This figure shows the co-authorship network connecting the top 25 collaborators of Candace M. Howard. A scholar is included among the top collaborators of Candace M. Howard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Candace M. Howard. Candace M. Howard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mok, Yejin, Shoshana H. Ballew, Jennifer A. Schrack, et al.. (2025). Mid-life physical activity and calcification of coronary arteries, aorta, and cardiac valves in late life: The Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis. 402. 119115–119115. 2 indexed citations
2.
Herzog, Thomas J., Thomas C. Krivak, Stephen Bush, et al.. (2025). ChemoID-guided therapy improves objective response rate in recurrent platinum-resistant ovarian cancer randomized clinical trial. npj Precision Oncology. 9(1). 86–86. 1 indexed citations
3.
Ejiri, Kentaro, Ning Ding, Esther Kim, et al.. (2024). Association of Segment‐Specific Pulse Wave Velocity With Vascular Calcification: The ARIC (Atherosclerosis Risk in Communities) Study. Journal of the American Heart Association. 13(2). e031778–e031778. 4 indexed citations
4.
5.
6.
7.
Spirito, Francesca, Pier Paolo Claudio, Candace M. Howard, et al.. (2023). A New and Effective Procedure for Advanced Oral Cancer Therapy: The Potential of a Cancer Stem Cell Assay in Guiding Chemotherapy. PubMed. 25(1). 16–27. 4 indexed citations
8.
Wang, Frances, Miguel Cainzos‐Achirica, Shoshana H. Ballew, et al.. (2023). Defining Demographic-specific Coronary Artery Calcium Percentiles in the Population Aged ≥75: The ARIC Study and MESA. Circulation Cardiovascular Imaging. 16(9). e015145–e015145. 4 indexed citations
9.
Obisesan, Olufunmilayo H., Minghao Kou, Frances Wang, et al.. (2022). Lipoprotein(a) and Subclinical Vascular and Valvular Calcification on Cardiac Computed Tomography: The Atherosclerosis Risk in Communities Study. Journal of the American Heart Association. 11(11). e024870–e024870. 31 indexed citations
10.
11.
Cortese, Antonio, et al.. (2021). Epi-Mucosa Fixation and Autologous Platelet-Rich Fibrin Treatment in Medication-Related Osteonecrosis of the Jaw. Dentistry Journal. 9(5). 50–50. 5 indexed citations
12.
Howard, Candace M., et al.. (2020). Left ventricular pseudoaneurysm: An unexpected finding. SHILAP Revista de lepidopterología. 16(3). 538–542. 6 indexed citations
13.
Greco, Adelaide, Sandra Albanese, Luigi Auletta, et al.. (2017). Advances in molecular preclinical therapy mediated by imaging. The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 61(1). 76–94. 4 indexed citations
14.
Howard, Candace M., et al.. (2017). Analysis of chemo-predictive assay for targeting cancer stem cells in 41 glioblastoma patients.. Journal of Clinical Oncology. 35(15_suppl). e13544–e13544. 4 indexed citations
15.
Greco, Adelaide, Candace M. Howard, Yulia Dementieva, et al.. (2009). Eradication of Therapy-resistant Human Prostate Tumors Using an Ultrasound-guided Site-specific Cancer Terminator Virus Delivery Approach. Molecular Therapy. 18(2). 295–306. 67 indexed citations
16.
Claudio, Pier Paolo, Candace M. Howard, Yan Fu, et al.. (2000). Mutations in the retinoblastoma-related gene RB2/p130 in primary nasopharyngeal carcinoma.. PubMed. 60(1). 8–12. 61 indexed citations
17.
Pupa, Serenella M., Candace M. Howard, R. Vecchi, et al.. (1999). Ectopic expression of pRb2/p130 suppresses the tumorigenicity of the c-erbB-2-overexpressing SKOV3 tumor cell line. Oncogene. 18(3). 651–656. 21 indexed citations
18.
Susini, Tommaso, Feliciano Baldi, Candace M. Howard, et al.. (1998). Expression of the retinoblastoma-related gene Rb2/p130 correlates with clinical outcome in endometrial cancer.. Journal of Clinical Oncology. 16(3). 1085–1093. 71 indexed citations
19.
Luca, Antonio De, Alfonso Baldi, Vincenzo Esposito, et al.. (1997). The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas. Nature Medicine. 3(8). 913–916. 167 indexed citations
20.
Luca, Antonio De, Timothy K. MacLachlan, Luigi Bagella, et al.. (1997). A Unique Domain of pRb2/p130 Acts as an Inhibitor of Cdk2 Kinase Activity. Journal of Biological Chemistry. 272(34). 20971–20974. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caterina Catricalà Breakdown of academic impact, for papers by Ken Berean Breakdown of academic impact, for papers by Nanette J. Liégeois Breakdown of academic impact, for papers by Claire Lugassy Breakdown of academic impact, for papers by Alistair Robson Breakdown of academic impact, for papers by W Domagała Breakdown of academic impact, for papers by Natalia Aptsiauri Breakdown of academic impact, for papers by Keichiro Mihara Breakdown of academic impact, for papers by Tai‐Gyu Kim Breakdown of academic impact, for papers by Anna Maria Cesinaro
Rankless by CCL
2026